Even if BUD has a great Dec qtr, sales-wise the company should still be screwed. This would require them to sell all of their inventory and due to critical component supply issues, they will be unable to replenish. They would have to raise capital to feed the corporate leeches in the abyss, without any indication the supply issue will improve until at least 2023.
Basically, BUD cannot afford to have a great (or even good) Dec qtr, as it would likely be the death knell for the company (if it isn't already). They need to ration out what inventory they have for as long as possible (and have said as much in previous updates).
- Forums
- ASX - By Stock
- BUD
- Ann: Appendix 4C August 2021
Ann: Appendix 4C August 2021, page-163
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BUD (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online